HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company dedicated to transforming the detection and monitoring of critical cardiac conditions. The Company is creating the first ever cable-free device capable of collecting ECG signals in 3D, from 3 non-co-planar directions, and synthesizing the signals into a 12-lead ECG. This platform technology is designed for portable devices that can be used wherever the patient is to deliver actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care – all outside of a medical facility, thus redefining the future of cardiac health management. HeartBeam’s 3D ECG technology received FDA clearance for arrhythmia assessment in December 2024.
Company Details
- Employees
- 31
- Founded
- -
- Address
- 2118 Walsh Ave,
- in****@****eam.com
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- heartbeam.com
- HQ
- Santa Clara , CA
Heartbeam Inc. (Nasdaq: Beat) Questions
Heartbeam Inc. (Nasdaq: Beat)'s website is heartbeam.com
Heartbeam Inc. (Nasdaq: Beat)'s LinkedIn profile is https://www.linkedin.com/company/heartbeam-inc
Heartbeam Inc. (Nasdaq: Beat) has
31 employees.
View email and phone details for 31
employees at Heartbeam Inc. (Nasdaq: Beat).
Heartbeam Inc. (Nasdaq: Beat)'s industry is
Medical Equipment Manufacturing
Heartbeam Inc. (Nasdaq: Beat)'s top competitors are
Cardiacare,
Spinafx,
Heartflow,
Volta Medical,
Happitech,
Epitel,
Acarix,
Biobeat,
Accurkardia,
Bivacor.
Heartbeam Inc. (Nasdaq: Beat)'s support email address is info@heartbeam.com
Heartbeam Inc. (Nasdaq: Beat)'s categories are Medical Equipment Manufacturing
Heartbeam Inc. (Nasdaq: Beat)'s founding year is 2015
